Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects

NCT ID: NCT01440426

Last Updated: 2018-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

187 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study deals with coverage of multiple denuded roots. The current standard treatment requires surgical correction and uses soft tissue taken from the roof of the mouth to enhance results. The hypothesis of this trial is that a synthetic collagen matrix (called Mucograft) can be used to replace soft tissue taken from the subject. If the collagen matrix will prove to be equally as effective as the patient own tissue, it will be possible to avoid a more extensive surgery and decrease pain and discomfort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives The main objective of this study is to assess if the Mucograft Collagen Matrix reduces morbidity, shortens time to recovery and improves patient based outcomes with respect to the use of autologous connective tissue graft harvested from the patient own palate when used to obtain root coverage of multiple adjacent gingival recessions.

The secondary objective is to assess the non-inferiority - in terms of complete root coverage, percentage of root coverage and professional evaluation of aesthetics - of the use of Mucograft Collagen Matrix and autologous connective tissue harvested from the patient's own palate.

Design and Outcomes This will be a parallel group, standard of care-controlled, assessor-blind, randomized, multicenter, multinational, clinical trial.

The statistical design will be a superiority trial in terms of the primary outcomes (patient based outcomes) and non-inferiority trial in terms of the professional outcomes measuring root coverage and aesthetics.

Sample size has been estimated in 140 subjects per treatment arm using a pilot case series analyzed with a multilevel statistical approach and a non inferiority margin of 0.25 mm in recession coverage.

Randomization will be performed by computer generated random codes, using random permuted blocks with a block size of 4 to avoid uneven splits and minimization for the key prognostic factor cigarette smoking. Allocation will be concealed to the surgeons until completion of preparation of the recipient bed by opaque envelopes. A central study registrar will perform patient registration.

Study locations will include academic centers and a practice-based research network in Italy, Switzerland, Germany, Belgium, France, Spain and Greece.

A single examiner, blind with respect to the treatment assignment, will perform all measurements at each center. Trained personnel not involved with the surgical intervention will: i) administer patient questionnaires, ii) provide instructions and collect patient diaries. A single calibrated investigator with specific experience in using the specific score will centrally perform assessment of esthetic scores on standardized digital images.

A biostatistician blind with respect to treatment assignment will perform the analysis.

Interventions and Duration The two intervention groups will consist of surgery with connective tissue graft (standard of care control) and surgery with the application of Mucograft Collagen Matrix (MCM, Test group). Experienced clinicians will deliver treatment consisting of root coverage surgery using coronally advanced flaps, the most utilized procedure for coverage of multiple recessions. Surgery will be standardized and the same procedures/materials will be employed to ensure consistency.

Follow-up of individual patients will be 6 months (to be extended to 3 years if funding will be available)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingival Recession

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autologous connective tissue graft

Soft tissue harvested from patient palate

Group Type ACTIVE_COMPARATOR

Autologous connective tissue graft with rotated papilla flap

Intervention Type PROCEDURE

Subepithelial connective tissue graft harvested from hard palate

Collagen Matrix Construct

Mucograft collagen matrix manufactured by Geistlich AG, Switzerland

Group Type EXPERIMENTAL

Collagen matrix construct (Mucograft)

Intervention Type DEVICE

Mucograft Collagen Matrix combined with rotated papilla flap

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Autologous connective tissue graft with rotated papilla flap

Subepithelial connective tissue graft harvested from hard palate

Intervention Type PROCEDURE

Collagen matrix construct (Mucograft)

Mucograft Collagen Matrix combined with rotated papilla flap

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Subepithelial connective tissue graft Mucograft gingival augmentation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 2-4 adjacent gingival recession (one at least 3 mm deep)

Exclusion Criteria

* Interdental attachment loss greater than 1 mm at recession sites
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The European Research Group on Periodontology (ERGOPerio)

NETWORK

Sponsor Role collaborator

Maurizio Tonetti

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maurizio Tonetti

Executive DIrector

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maurizio Tonetti, DMD PhD

Role: PRINCIPAL_INVESTIGATOR

The European Research Group on Periodontology (ERGOPerio)

Pierpaolo COrtellini, MD

Role: PRINCIPAL_INVESTIGATOR

The European Research Group on Periodontology (ERGOPerio)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ICPDOI

Brussels, , Belgium

Site Status

Praxis Dr. Halben

Hamburg, , Germany

Site Status

Praxis Prof Huerzeler - Dr Zuhr

Munich, , Germany

Site Status

Praxis Prof Wachtel - Dr Bolz

Munich, , Germany

Site Status

Praxis Prof. Topoll

Münster, , Germany

Site Status

Clinic Fourmousis

Athens, , Greece

Site Status

University of FLorence

Florence, , Italy

Site Status

Practice Prof Giulio Rasperini

Piacenza, , Italy

Site Status

University of Pisa

Pisa, , Italy

Site Status

Clinia Zabalegui

Bilbao, , Spain

Site Status

Clinica Guerrero

Málaga, , Spain

Site Status

Praxis Wallkamm

Langenthal, , Switzerland

Site Status

Praxis Burkhardt

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Germany Greece Italy Spain Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ERGOPerio 11-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Multiple Gingival Recessions
NCT02818855 COMPLETED PHASE4